{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:17:34Z","timestamp":1794338254319,"version":"4.9.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41584-018-0004-x","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T11:41:25Z","timestamp":1525779685000},"page":"341-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":325,"title":["An update on the genetics of hyperuricaemia and gout"],"prefix":"10.1038","volume":"14","author":[{"given":"Tanya J.","family":"Major","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli A.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth, N., Merriman, T. R. & Stamp, L. K. Gout. Lancet 388, 2039\u20132052 (2016).","journal-title":"Lancet"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu, Y., Pandya, B. J. & Choi, H. K. Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007\u20132008. Arthritis Rheum. 63, 3136\u20133141 (2011).","journal-title":"Arthritis Rheum."},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","volume":"74","author":"P Richette","year":"2015","unstructured":"Richette, P., Clerson, P., Perissin, L., Flipo, R. M. & Bardin, T. Revisiting comorbidities in gout: a cluster analysis. Ann. Rheum. Dis. 74, 142\u2013147 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.maturitas.2014.05.001","volume":"78","author":"PC Robinson","year":"2014","unstructured":"Robinson, P. C. & Hosburgh, S. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas 78, 245\u2013251 (2014).","journal-title":"Maturitas"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","volume":"17","author":"TR Merriman","year":"2015","unstructured":"Merriman, T. R. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res. Ther. 17, 98 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","volume":"82","author":"EW Campion","year":"1987","unstructured":"Campion, E. W., Glynn, R. J. & DeLabry, L. O. Asymptomatic hyperuricemia. risks and consequences normative aging study. Am. J. Med. 82, 421\u2013426 (1987).","journal-title":"Am. J. Med."},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.amjmed.2011.11.010","volume":"125","author":"E Krishnan","year":"2012","unstructured":"Krishnan, E., Lessov-Schlaggar, C. N., Krasnow, R. E. & Swan, G. E. Nature versus nurture in gout: a twin study. Am. J. Med. 125, 499\u2013504 (2012).","journal-title":"Am. J. Med."},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gepi.1370040102","volume":"4","author":"S Kalousdian","year":"1987","unstructured":"Kalousdian, S., Fabsitz, R., Havlik, R., Christian, J. & Rosenman, R. Heritability of clinical chemistries in an older twin cohort: the NHLBI Twin Study. Genet. Epidemiol. 4, 1\u201311 (1987).","journal-title":"Genet. Epidemiol."},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1017\/S0001566000006401","volume":"32","author":"J Whitfield","year":"1983","unstructured":"Whitfield, J. & Martin, N. Inheritance and alcohol as factors influencing plasma uric acid levels. Acta Genet. Med. Gemello 32, 117\u2013126 (1983).","journal-title":"Acta Genet. Med. Gemello"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/ard.51.3.375","volume":"51","author":"BT Emmerson","year":"1992","unstructured":"Emmerson, B. T., Nagel, S. L., Duffy, D. L. & Martin, N. G. Genetic control of the renal clearance of urate: a study of twins. Ann. Rheum. Dis. 51, 375\u2013377 (1992).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0022-5347(06)00272-2","volume":"175","author":"M Monga","year":"2006","unstructured":"Monga, M., Macias, B., Groppo, E. & Hargens, A. Genetic heritability of urinary stone risk in identical twins. J. Urol. 175, 2125\u20132128 (2006).","journal-title":"J. Urol."},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/00365510902814646","volume":"69","author":"SE Nilsson","year":"2009","unstructured":"Nilsson, S. E., Read, S., Berg, S. & Johansson, B. Heritabilities for fifteen routine biochemical values: findings in 215 Swedish twin pairs 82 years of age or older. Scan. J. Clin. Lab. Invest. 69, 562\u2013569 (2009).","journal-title":"Scan. J. Clin. Lab. Invest."},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2010","unstructured":"Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76\u201382 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A Kottgen","year":"2013","unstructured":"Kottgen, A. et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat. Genet. 45, 145\u2013154 (2013).","journal-title":"Nat. Genet."},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13075-017-1390-1","volume":"19","author":"M Cadzow","year":"2017","unstructured":"Cadzow, M., Merriman, T. R. & Dalbeth, N. Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank. Arthritis Res. Ther. 19, 181 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/art.10792","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz, F., Calabozo, M., Erauskin, G. G., Ruibal, A. & Herrero-Beites, A. M. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum. 47, 610\u2013613 (2002).","journal-title":"Arthritis Rheum."},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756","volume":"3","author":"K Ichida","year":"2012","unstructured":"Ichida, K. et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat. Comm. 3, 764 (2012).","journal-title":"Nat. Comm."},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna, D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic non-pharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 64, 1431\u20131436 (2012).","journal-title":"Arthritis Care Res."},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette, P. et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann. Rheum. Dis. 76, 29\u201342 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.semarthrit.2014.05.007","volume":"44","author":"LK Stamp","year":"2014","unstructured":"Stamp, L. K. et al. Impaired response or insufficient dosage? Examining the potential causes of \u201cinadequate response\u201d to allopurinol in the treatment of gout. Semin. Arthritis Rheum. 44, 170\u2013174 (2014).","journal-title":"Semin. Arthritis Rheum."},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","volume":"74","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth, N. et al. Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study. Ann. Rheum. Dis. 74, 908\u2013911 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/ard.2006.063768","volume":"66","author":"E Roddy","year":"2007","unstructured":"Roddy, E., Zhang, W. & Doherty, M. Are joints affected by gout also affected by osteoarthritis? Ann. Rheum. Dis. 66, 1374\u20131377 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/annrheumdis-2012-202786","volume":"72","author":"N Dalbeth","year":"2013","unstructured":"Dalbeth, N. et al. Tendon involvement in the feet of patients with gout: a dual-energy CT study. Ann. Rheum. Dis. 72, 1545\u20131548 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-015-0762-4","volume":"16","author":"A Chhana","year":"2015","unstructured":"Chhana, A., Lee, G. & Dalbeth, N. Factors influencing the crystallization of monosodium urate: a systematic literature review. BMC Musculoskelet. Disord. 16, 296 (2015).","journal-title":"BMC Musculoskelet. Disord."},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/art.27356","volume":"62","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth, N. et al. Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum. 62, 1549\u20131556 (2010).","journal-title":"Arthritis Rheum."},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/rheumatology\/23.4.276","volume":"23","author":"T Gibson","year":"1984","unstructured":"Gibson, T., Waterworth, R., Hatfield, P., Robinson, G. & Bremner, K. Hyperuricaemia, gout and kidney function in New Zealand Maori men. Br. J. Rheumatol. 23, 276\u2013282 (1984).","journal-title":"Br. J. Rheumatol."},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng.2352","volume":"44","author":"Y Okada","year":"2012","unstructured":"Okada, Y. et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat. Genet. 44, 904\u2013909 (2012).","journal-title":"Nat. Genet."},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1093\/hmg\/ddr307","volume":"20","author":"A Tin","year":"2011","unstructured":"Tin, A. et al. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum. Mol. Genet. 20, 4056\u20134068 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan, A. et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372, 1953\u20131961 (2008).","journal-title":"Lancet"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.1038\/ncomms8041","volume":"6","author":"C Li","year":"2015","unstructured":"Li, C. et al. Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese. Nat. Comm. 6, 7041 (2015).","journal-title":"Nat. Comm."},{"key":"4_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04127-4","volume":"7","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. Replication of gout\/urate concentrations GWAS susceptibility loci associated with gout in a Han Chinese population. Sci. Rep. 7, 4094 (2017).","journal-title":"Sci. Rep."},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/annrheumdis-2014-206191","volume":"75","author":"H Matsuo","year":"2016","unstructured":"Matsuo, H. et al. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes. Ann. Rheum. Dis. 75, 652\u2013659 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/annrheumdis-2014-205877","volume":"75","author":"AJ Phipps-Green","year":"2016","unstructured":"Phipps-Green, A. J. et al. Twenty-eight loci that influence serum urate levels: analysis of association with gout. Ann. Rheum. Dis. 75, 124\u2013130 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3899\/jrheum.121244","volume":"40","author":"W Urano","year":"2013","unstructured":"Urano, W. et al. Effect of genetic polymorphisms on development of gout. J. Rheumatol. 40, 1374\u20131378 (2013).","journal-title":"J. Rheumatol."},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1136\/annrheumdis-2013-203600","volume":"73","author":"C Batt","year":"2013","unstructured":"Batt, C. et al. Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann. Rheum. Dis. 73, 2101\u20132106 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13075-015-0802-3","volume":"17","author":"C McKinney","year":"2015","unstructured":"McKinney, C. et al. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Res. Ther. 17, 288 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13075-017-1369-y","volume":"19","author":"H Rasheed","year":"2017","unstructured":"Rasheed, H., Stamp, L. K., Dalbeth, N. & Merriman, T. R. Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout. Arthritis Res. Ther. 19, 161 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"R177","DOI":"10.1186\/ar4366","volume":"15","author":"H Rasheed","year":"2013","unstructured":"Rasheed, H. et al. Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption. Arthritis Res. Ther. 15, R177 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"4_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2156-15-81","volume":"15","author":"RB Scharpf","year":"2014","unstructured":"Scharpf, R. B. et al. Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations. BMC Genet. 15, 81 (2014).","journal-title":"BMC Genet."},{"key":"4_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000464","volume":"3","author":"T Higashino","year":"2017","unstructured":"Higashino, T. et al. Multiple common and rare variants of ABCG2 cause gout. RMD Open 3, e000464 (2017).","journal-title":"RMD Open"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kex295","volume":"56","author":"B Stiburkova","year":"2017","unstructured":"Stiburkova, B. et al. Functional non-synonymous variants of ABCG2 and gout risk. Rheumatology 56, 1982\u20131992 (2017).","journal-title":"Rheumatology"},{"issue":"Suppl. 10","key":"4_CR43","first-page":"2273","volume":"68","author":"J Boocock","year":"2016","unstructured":"Boocock, J. et al. Trans-ancestral meta-analysis identifies nine new loci associated with serum uric acid concentrations [abstract]. Arthritis Rheumatol. 68 (Suppl. 10), 2273 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.rdc.2014.01.009","volume":"40","author":"TR Merriman","year":"2014","unstructured":"Merriman, T. R., Choi, H. K. & Dalbeth, N. The genetic basis of gout. Rheum. Dis. Clin. North Am. 40, 279\u2013290 (2014).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","volume":"169","author":"EA Boyle","year":"2017","unstructured":"Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177\u20131186 (2017).","journal-title":"Cell"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng.107","volume":"40","author":"A Doring","year":"2008","unstructured":"Doring, A. et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat. Genet. 40, 430\u2013436 (2008).","journal-title":"Nat. Genet."},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ng.106","volume":"40","author":"V Vitart","year":"2008","unstructured":"Vitart, V. et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 40, 437\u2013442 (2008).","journal-title":"Nat. Genet."},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/PGPM.S105854","volume":"10","author":"M Cleophas","year":"2017","unstructured":"Cleophas, M. et al. ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmacogenomics Pers. Med. 10, 129\u2013142 (2017).","journal-title":"Pharmacogenomics Pers. Med."},{"key":"4_CR49","first-page":"S10","volume":"69","author":"TR Merriman","year":"2017","unstructured":"Merriman, T. R. et al. Non-coding genetic variant maximally associated with serum urate levels is functionally linked to HNF4A-dependent PDZK1 expression [abstract]. Arthritis Rheumatol. 69, S10 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","volume":"18","author":"NL Beer","year":"2009","unstructured":"Beer, N. L. et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum. Mol. Genet. 18, 4081\u20134088 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00125-011-2348-5","volume":"55","author":"M Rees","year":"2012","unstructured":"Rees, M. et al. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia 55, 114\u2013122 (2012).","journal-title":"Diabetologia"},{"key":"4_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep25360","volume":"6","author":"M Sakiyama","year":"2016","unstructured":"Sakiyama, M. et al. Identification of rs671, a common variant of ALDH2, as a gout susceptibility locus. Sci. Rep. 6, 25360 (2016).","journal-title":"Sci. Rep."},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/ng.972","volume":"43","author":"P Sulem","year":"2011","unstructured":"Sulem, P. et al. Identification of low-frequency variants associated with gout and serum uric acid levels. Nat. Genet. 43, 1127\u20131130 (2011).","journal-title":"Nat. Genet."},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/jhg.2012.39","volume":"57","author":"J Shin","year":"2012","unstructured":"Shin, J., Kim, Y., Kong, M. & Lee, C. Genetic architecture for susceptibility to gout in the KARE cohort study. J. Hum. Genet. 57, 379\u2013384 (2012).","journal-title":"J. Hum. Genet."},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s00125-013-3047-1","volume":"56","author":"JZ Kuo","year":"2013","unstructured":"Kuo, J. Z. et al. Trans-ethnic fine mapping identifies a novel independent locus at the 3' end of CDKAL1 and novel variants of several susceptibility loci for type 2 diabetes in a Han Chinese population. Diabetologia 56, 2619\u20132628 (2013).","journal-title":"Diabetologia"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/annrheumdis-2016-209632","volume":"76","author":"A Nakayama","year":"2017","unstructured":"Nakayama, A. et al. GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Ann. Rheum. Dis. 76, 869\u2013877 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0140-6736(17)33150-1","volume":"4","author":"C Li","year":"2017","unstructured":"Li, C. et al. Genetic variants associated with tophi occurrence by a genome wide association study of 1888 patients. Gout and Hyperuricemia 4, 12\u201320 (2017).","journal-title":"Gout and Hyperuricemia"},{"key":"4_CR58","first-page":"S10","volume":"69","author":"TR Merriman","year":"2017","unstructured":"Merriman, T. R. et al. Genome-wide association study of gout in people of European ancestry [abstract]. Arthritis Rheumatol. 69, S10 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cbi.2012.12.018","volume":"202","author":"V Vasiliou","year":"2013","unstructured":"Vasiliou, V. et al. ALDH16A1 is a novel non-catalytic enzyme that may be involved in the etiology of gout via protein\u2013protein interactions with HPRT1. Chem. Biol. Interact. 202, 22\u201331 (2013).","journal-title":"Chem. Biol. Interact."},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cbi.2017.02.013","volume":"276","author":"G Charkoftaki","year":"2017","unstructured":"Charkoftaki, G. et al. Transcriptomic analysis and plasma metabolomics in Aldh16a1-null mice reveals a potential role of ALDH16A1 in renal function. Chem. Biol. Interact. 276, 15\u201322 (2017).","journal-title":"Chem. Biol. Interact."},{"key":"4_CR61","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/ar3816","volume":"14","author":"JE Hollis-Moffatt","year":"2012","unstructured":"Hollis-Moffatt, J. E. et al. The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res. Ther. 14, R92 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/art.40110","volume":"69","author":"C Tanner","year":"2017","unstructured":"Tanner, C. et al. Population-specific resequencing associates the ATP-binding cassette subfamily C member 4 gene with gout in New Zealand M\u0101ori and Pacific men. Arthritis Rheumatol. 69, 1461\u20131469 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"4_CR63","doi-asserted-by":"crossref","first-page":"13854","DOI":"10.1016\/S0021-9258(17)36725-X","volume":"269","author":"J Farr\u00e9s","year":"1994","unstructured":"Farr\u00e9s, J. et al. Effects of changing glutamate 487 to lysine in rat and human liver mitochondrial aldehyde dehydrogenase. A model to study human (Oriental type) class 2 aldehyde dehydrogenase. J. Biol. Chem. 269, 13854\u201313860 (1994).","journal-title":"J. Biol. Chem."},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4615-2584-4_13","volume":"370","author":"H Yamanaka","year":"1994","unstructured":"Yamanaka, H. et al. Analysis of the genotypes for aldehyde dehydrogenase 2 in Japanese patients with primary gout. Adv. Exp. Med. Biol. 370, 53\u201356 (1994).","journal-title":"Adv. Exp. Med. Biol."},{"key":"4_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064845","volume":"8","author":"YF Qing","year":"2013","unstructured":"Qing, Y. F. et al. Association of TLR4 gene rs2149356 polymorphism with primary gouty arthritis in a case-control study. PLoS ONE 8, e64845 (2013).","journal-title":"PLoS ONE"},{"key":"4_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147939","volume":"11","author":"H Rasheed","year":"2016","unstructured":"Rasheed, H. et al. The Toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and Polynesian sample sets. PLoS ONE 11, e0147939 (2016).","journal-title":"PLoS ONE"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1159\/000373960","volume":"35","author":"Y Chen","year":"2015","unstructured":"Chen, Y. et al. CARD 8 rs2043211 polymorphism is associated with gout in a Chinese male population. Cell. Physiol. Biochem. 35, 1394\u20131400 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/carcin\/bgp122","volume":"30","author":"NE Landvik","year":"2009","unstructured":"Landvik, N. E. et al. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis 30, 1186\u20131192 (2009).","journal-title":"Carcinogenesis"},{"key":"4_CR69","doi-asserted-by":"publisher","first-page":"E816","DOI":"10.1210\/jc.2010-2455","volume":"96","author":"J Delgado-Lista","year":"2011","unstructured":"Delgado-Lista, J. et al. Interleukin 1B variant-1473G\/C (rs1143623) influences triglyceride and interleukin 6 metabolism. J. Clin. Endocrinol. Metab. 96, E816\u2013E820 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4_CR70","first-page":"457","volume":"56","author":"WC Chang","year":"2017","unstructured":"Chang, W. C. et al. Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis. Rheumatology 56, 457\u2013466 (2017).","journal-title":"Rheumatology"},{"issue":"Suppl. 10","key":"4_CR71","first-page":"1127","volume":"69","author":"A Shaukat","year":"2017","unstructured":"Shaukat, A. et al. Replication of genetic association of peroxisome proliferator-activated receptor gamma-1B with gout in a New Zealand Polynesian sample set [abstract]. Arthritis Rheumatol. 69 (Suppl. 10), 1127 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"4_CR72","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/annrheumdis-2017-212416","volume":"77","author":"AL Gosling","year":"2017","unstructured":"Gosling, A. L. et al. Mitochondrial genetic variation and susceptibility to gout in Maori and Pacific people living in Aotearoa New Zealand. Ann. Rheum. Dis. 77, 571\u2013578 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR73","first-page":"323","volume":"56","author":"T Merriman","year":"2017","unstructured":"Merriman, T. & Terkeltaub, R. PPARGC1B: insight into the expression of the gouty inflammation phenotype: PPARGC1B and gouty inflammation. Rheumatology 56, 323\u2013325 (2017).","journal-title":"Rheumatology"},{"key":"4_CR74","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/ard.2003.019695","volume":"64","author":"F Cardona","year":"2005","unstructured":"Cardona, F. et al. Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout. Ann. Rheum. Dis. 64, 85\u201388 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR75","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/rheumatology\/kew057","volume":"55","author":"H Rasheed","year":"2016","unstructured":"Rasheed, H. et al. Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout. Rheumatology 55, 1421\u20131430 (2016).","journal-title":"Rheumatology"},{"key":"4_CR76","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1182\/blood.V97.8.2381","volume":"97","author":"N Hyka","year":"2001","unstructured":"Hyka, N. et al. Apolipoprotein AI inhibits the production of interleukin-1\u03b2 and tumor necrosis factor-\u03b1 by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97, 2381\u20132389 (2001).","journal-title":"Blood"},{"key":"4_CR77","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/03009742.2014.903994","volume":"43","author":"S Chiang","year":"2014","unstructured":"Chiang, S. et al. Increased level of MSU crystal-bound protein apolipoprotein AI in acute gouty arthritis. Scand. J. Rheumatol. 43, 498\u2013502 (2014).","journal-title":"Scand. J. Rheumatol."},{"key":"4_CR78","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","volume":"75","author":"TO Cri\u0219an","year":"2016","unstructured":"Cri\u0218an, T. O. et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann. Rheum. Dis. 75, 755\u2013762 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/srep43614","volume":"7","author":"Z Dong","year":"2017","unstructured":"Dong, Z. et al. Effects of multiple genetic loci on the pathogenesis from serum urate to gout. Sci. Rep. 7, 43614 (2017).","journal-title":"Sci. Rep."},{"issue":"Suppl. 10","key":"4_CR80","first-page":"2276","volume":"68","author":"TR Merriman","year":"2016","unstructured":"Merriman, T. R. et al. Pleiotropic effect of ABCG2 in gout [abstract]. Arthritis Rheumatol. 68 (Suppl. 10), 2276 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"4_CR81","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1158\/0008-5472.CAN-11-2008","volume":"72","author":"A Basseville","year":"2012","unstructured":"Basseville, A. et al. Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter. Canc. Res. 72, 3642\u20133651 (2012).","journal-title":"Canc. Res."},{"key":"4_CR82","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00439-012-1151-9","volume":"131","author":"J Wang","year":"2012","unstructured":"Wang, J. et al. Association between gout and polymorphisms in GCKR in male Han Chinese. Hum. Genet. 131, 1261\u20131265 (2012).","journal-title":"Hum. Genet."},{"key":"4_CR83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","volume":"29","author":"M Kanbay","year":"2016","unstructured":"Kanbay, M. et al. Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur. J. Intern. Med. 29, 3\u20138 (2016).","journal-title":"Eur. J. Intern. Med."},{"key":"4_CR84","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nrrheum.2016.102","volume":"12","author":"PC Robinson","year":"2016","unstructured":"Robinson, P. C., Choi, H. K., Do, R. & Merriman, T. R. Insight into rheumatological cause and effect through the use of Mendelian randomization. Nat. Rev. Rheumatol. 12, 486\u2013496 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"4_CR85","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ki.2013.353","volume":"85","author":"K Hughes","year":"2014","unstructured":"Hughes, K., Flynn, T., de Zoysa, J., Dalbeth, N. & Merriman, T. R. Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. Kidney Int. 85, 344\u2013351 (2014).","journal-title":"Kidney Int."},{"key":"4_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039321","volume":"7","author":"T Lyngdoh","year":"2012","unstructured":"Lyngdoh, T. et al. Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach. PLoS ONE 7, e39321 (2012).","journal-title":"PLoS ONE"},{"key":"4_CR87","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCGENETICS.114.000556","volume":"7","author":"H Rasheed","year":"2014","unstructured":"Rasheed, H., Hughes, K., Flynn, T. J. & Merriman, T. R. Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels. Circ. Cardiovasc. Genet. 7, 830\u2013837 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"4_CR88","doi-asserted-by":"publisher","first-page":"f4262","DOI":"10.1136\/bmj.f4262","volume":"347","author":"TM Palmer","year":"2013","unstructured":"Palmer, T. M. et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts. Br. Med. J. 347, f4262 (2013).","journal-title":"Br. Med. J."},{"key":"4_CR89","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jacc.2015.10.086","volume":"67","author":"T Keenan","year":"2016","unstructured":"Keenan, T. et al. Causal assessment of serum urate levels in cardiometabolic diseases through a Mendelian randomization study. J. Am. Coll. Cardiol. 67, 407\u2013416 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4_CR90","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.2337\/db14-0742","volume":"64","author":"I Sluijs","year":"2015","unstructured":"Sluijs, I. et al. A Mendelian randomization study of circulating uric acid and type 2 diabetes. Diabetes 64, 3028\u20133036 (2015).","journal-title":"Diabetes"},{"key":"4_CR91","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S2213-8587(15)00386-1","volume":"4","author":"J White","year":"2016","unstructured":"White, J. et al. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 4, 327\u2013336 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0878-5","volume":"15","author":"N Dalbeth","year":"2017","unstructured":"Dalbeth, N., Stamp, L. K. & Merriman, T. R. The genetics of gout: towards personalised medicine? BMC Med. 15, 108 (2017).","journal-title":"BMC Med."},{"key":"4_CR93","doi-asserted-by":"publisher","first-page":"h4848","DOI":"10.1136\/bmj.h4848","volume":"351","author":"TM Ko","year":"2015","unstructured":"Ko, T. M. et al. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ 351, h4848 (2015).","journal-title":"BMJ"},{"key":"4_CR94","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13075-017-1254-8","volume":"19","author":"W He","year":"2017","unstructured":"He, W., Phipps-Green, A., Stamp, L. K., Merriman, T. R. & Dalbeth, N. Population-specific association between ABCG2 variants and tophaceous disease in people with gout. Arthritis Res. Ther. 19, 43 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"4_CR95","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1093\/hmg\/ddv145","volume":"24","author":"A Spiliopoulou","year":"2015","unstructured":"Spiliopoulou, A. et al. Genomic prediction of complex human traits: relatedness, trait architecture and predictive meta-models. Hum. Mol. Genet. 24, 4167\u20134182 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"4_CR96","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/cpt.89","volume":"97","author":"CC Wen","year":"2015","unstructured":"Wen, C. C. et al. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. Clin. Pharmacol. Ther. 97, 518\u2013525 (2015).","journal-title":"Clin. Pharmacol. Ther."},{"key":"4_CR97","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/tpj.2015.101","volume":"17","author":"RL Roberts","year":"2017","unstructured":"Roberts, R. L. et al. ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout. Pharmacogenomics J. 17, 201\u2013203 (2017).","journal-title":"Pharmacogenomics J."},{"key":"4_CR98","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/rheumatology\/kex467","volume":"57","author":"MC Wallace","year":"2018","unstructured":"Wallace, M. C. et al. Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis. Rheumatology 57, 656\u2013660 (2018).","journal-title":"Rheumatology"},{"key":"4_CR99","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/01.ASN.0000105320.04395.D0","volume":"15","author":"K Ichida","year":"2004","unstructured":"Ichida, K. et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J. Am. Soc. Nephrol. 15, 164\u2013173 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"4_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-17","volume":"4","author":"BA Charles","year":"2011","unstructured":"Charles, B. A. et al. A genome-wide association study of serum uric acid in African Americans. BMC Med. Genomics 4, 17 (2011).","journal-title":"BMC Med. Genomics"},{"key":"4_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-016-0366-3","volume":"18","author":"G Chittoor","year":"2017","unstructured":"Chittoor, G. et al. Genetic variation underlying renal uric acid excretion in Hispanic children: the Viva La Familia Study. BMC Med. Genet. 18, 6 (2017).","journal-title":"BMC Med. Genet."},{"key":"4_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/srep21440","volume":"6","author":"AK Giri","year":"2016","unstructured":"Giri, A. K. et al. Genome wide association study of uric acid in Indian population and interaction of identified variants with type 2 diabetes. Sci. Rep. 6, 21440 (2016).","journal-title":"Sci. Rep."},{"key":"4_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119752","volume":"10","author":"JE Huffman","year":"2015","unstructured":"Huffman, J. E. et al. Modulation of genetic associations with serum urate levels by body-mass-index in humans. PLoS ONE 10, e0119752 (2015).","journal-title":"PLoS ONE"},{"key":"4_CR104","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng.531","volume":"42","author":"Y Kamatani","year":"2010","unstructured":"Kamatani, Y. et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210\u2013215 (2010).","journal-title":"Nat. Genet."},{"key":"4_CR105","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1469-1809.2011.00698.x","volume":"76","author":"R Karns","year":"2012","unstructured":"Karns, R. et al. Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic Coast of Croatia. Ann. Hum. Genet. 76, 121\u2013127 (2012).","journal-title":"Ann. Hum. Genet."},{"key":"4_CR106","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/ddq510","volume":"20","author":"EE Kenny","year":"2010","unstructured":"Kenny, E. E. et al. Increased power of mixed models facilitates association mapping of 10 loci for metabolic traits in an isolated population. Hum. Mol. Genet. 20, 827\u2013839 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"4_CR107","doi-asserted-by":"publisher","first-page":"1000504","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz, M. et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, 1000504 (2009).","journal-title":"PLoS Genet."},{"key":"4_CR108","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ejhg.2015.85","volume":"24","author":"M Korostishevsky","year":"2016","unstructured":"Korostishevsky, M. et al. Genomics and metabolomics of muscular mass in a community-based sample of UK females. Eur. J. Hum. Genet. 24, 277\u2013283 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"4_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030194","volume":"3","author":"S Li","year":"2007","unstructured":"Li, S. et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3, e194 (2007).","journal-title":"PLoS Genet."},{"key":"4_CR110","doi-asserted-by":"crossref","first-page":"E490","DOI":"10.1002\/oby.20303","volume":"21","author":"WD Li","year":"2013","unstructured":"Li, W. D. et al. A genome wide association study of plasma uric acid levels in obese cases and never-overweight controls. Obesity 21, E490\u2013E494 (2013).","journal-title":"Obesity"},{"key":"4_CR111","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1002\/art.23752","volume":"58","author":"PF McArdle","year":"2008","unstructured":"McArdle, P. F. et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in Old Order Amish. Arthritis Rheum. 58, 2874\u20132881 (2008).","journal-title":"Arthritis Rheum."},{"key":"4_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-123","volume":"12","author":"RP Middelberg","year":"2011","unstructured":"Middelberg, R. P. et al. Genetic variants in LPL, OASL and TOMM40\/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits. BMC Med. Genet. 12, 123 (2011).","journal-title":"BMC Med. Genet."},{"key":"4_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0414-4","volume":"9","author":"R Nagy","year":"2017","unstructured":"Nagy, R. et al. Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants. Genome Med. 9, 23 (2017).","journal-title":"Genome Med."},{"issue":"Suppl. 2","key":"4_CR114","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/annrheumdis-2017-eular.4611","volume":"76","author":"TR Merriman","year":"2017","unstructured":"Merriman, T. R. et al. Trans-ancestral meta-analysis identifies 13 new loci associated with serum urate levels [abstract OP0263]. Ann. Rheum. Dis. 76 (Suppl. 2) 165 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"4_CR115","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3346\/jkms.2017.32.9.1451","volume":"32","author":"C-N Son","year":"2017","unstructured":"Son, C.-N. et al. ABCG2 polymorphism is associated with hyperuricemia in a study of a community-based Korean cohort. J. Korean Med. Sci. 32, 1451\u20131459 (2017).","journal-title":"J. Korean Med. Sci."},{"key":"4_CR116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature10354","volume":"477","author":"K Suhre","year":"2011","unstructured":"Suhre, K. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54\u201360 (2011).","journal-title":"Nature"},{"key":"4_CR117","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fgene.2013.00279","volume":"4","author":"VS Voruganti","year":"2013","unstructured":"Voruganti, V. S. et al. Genome-wide association analysis confirms and extends the association of SLC2A9 with serum uric acid levels to Mexican Americans. Front. Genet. 4, 279 (2013).","journal-title":"Front. Genet."},{"key":"4_CR118","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ajhg.2007.11.001","volume":"82","author":"C Wallace","year":"2008","unstructured":"Wallace, C. et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am. J. Hum. Genet. 82, 139\u2013149 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"4_CR119","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","volume":"3","author":"QO Yang","year":"2010","unstructured":"Yang, Q. O. et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ. Cardiovasc. Genet. 3, 523\u2013530 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"4_CR120","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3325\/cmj.2009.50.23","volume":"50","author":"T Zemunik","year":"2009","unstructured":"Zemunik, T. et al. Genome-wide association study of biochemical traits in Kor\u010dula Island, Croatia. Croat. Med. J. 50, 23\u201333 (2009).","journal-title":"Croat. Med. J."},{"key":"4_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-7-10","volume":"7","author":"B Yang","year":"2014","unstructured":"Yang, B. et al. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med. Genomics 7, 10 (2014).","journal-title":"BMC Med. Genomics"},{"key":"4_CR122","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00296-015-3364-4","volume":"36","author":"RJ Reynolds","year":"2016","unstructured":"Reynolds, R. J. et al. Serum urate gene associations with incident gout, measured in the Framingham heart study, are modified by renal disease and not by body mass index. Rheumatol. Int. 36, 263\u2013270 (2016).","journal-title":"Rheumatol. Int."},{"key":"4_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007729","volume":"4","author":"K Stark","year":"2009","unstructured":"Stark, K. et al. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS ONE 4, e7729 (2009).","journal-title":"PLoS ONE"},{"key":"4_CR124","first-page":"7503","volume":"9","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Associations of gout with polymorphisms in SLC2A9, WDR1, CLNK, PKD2, and ABCG2 Chinese Han and Tibetan populations. Int. J. Clin. Exp. Pathol. 9, 7503\u20137517 (2016).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"4_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-015-0208-8","volume":"16","author":"ZW Zhou","year":"2015","unstructured":"Zhou, Z. W. et al. Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case-control study. BMC Med. Genet. 16, 66 (2015).","journal-title":"BMC Med. Genet."},{"key":"4_CR126","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3906\/sag-1409-58","volume":"46","author":"C Zheng","year":"2016","unstructured":"Zheng, C., Yang, H., Wang, Q., Rao, H. & Diao, Y. Association analysis of five SNP variants with gout in the Minnan population in China. Turk. J. Med. Sci. 46, 361\u2013367 (2016).","journal-title":"Turk. J. Med. Sci."},{"key":"4_CR127","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3904\/kjim.2015.30.6.913","volume":"30","author":"YS Kim","year":"2015","unstructured":"Kim, Y. S. et al. Genetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean population. Korean J. Intern. Med. 30, 913\u2013920 (2015).","journal-title":"Korean J. Intern. Med."},{"key":"4_CR128","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.4238\/2015.March.30.13","volume":"14","author":"W Wan","year":"2015","unstructured":"Wan, W., Xu, X., Zhao, D., Pang, Y. & Wang, Y. Polymorphisms of uric transporter proteins in the pathogenesis of gout in a Chinese Han population. Genet. Mol. Res. 14, 2546\u20132550 (2015).","journal-title":"Genet. Mol. Res."},{"key":"4_CR129","doi-asserted-by":"publisher","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","volume":"1","author":"H Matsuo","year":"2009","unstructured":"Matsuo, H. et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci. Transl. Med. 1, 5ra11 (2009).","journal-title":"Sci. Transl. Med."},{"key":"4_CR130","first-page":"9812","volume":"8","author":"R Li","year":"2015","unstructured":"Li, R. et al. A meta-analysis of the associations between the Q141K and Q126X gene variants and gout risk. Int. J. Clin. Exp. Pathol. 8, 9812\u20139823 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"4_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/srep20148","volume":"6","author":"M Sakiyama","year":"2016","unstructured":"Sakiyama, M. et al. The effects of URAT1\/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout\/hyperuricemia progression. Sci. Rep. 6, 20148 (2016).","journal-title":"Sci. Rep."},{"key":"4_CR132","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333\u2013338 (2011).","journal-title":"Nat. Genet."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-018-0004-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-018-0004-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-018-0004-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:51:11Z","timestamp":1751611871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-018-0004-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1038\/s41584-018-0004-x","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"8 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.D. declares that she has received consulting fees, speaker fees or grants from Ardea\/AstraZeneca, Cymabay, Crealta, Horizon and Takeda, which have developed or marketed urate-lowering therapies for management of gout. T.R.M. declares that he has received consulting fees, speaker fees or grants from Ardea\/AstraZeneca and Horizon, which have developed or marketed urate-lowering therapies for management of gout. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}